Our Leadership

MicroPort Scientific Corporation (the "Company") consists of two geographically distinctive operational business units: Greater China and InterContinental, respectively managed by Greater China Executive Committee ("CEC") and two InterContinental committees.

Zhaohua Chang Ph.DExecutive Director
Dr. Zhaohua Chang is the Chairman and Chief Executive Officer of the Company, Chairperson of GMC. He has over 29 years' experience in the medical device industry, and currently also serve as a professor at School of Medical Instrument, University of Shanghai for Science and Technology. Before establishing Shanghai MicroPort Medical (Group) Co., Ltd. in 1998, from 1996 to 1997, Dr. Chang served as Vice President of Research and Development at Endocare Inc., a NASDAQ listed medical device company based in California. From 1990 to 1995, he served as Senior Engineer, Chief Scientist, Director of Research and Development and Vice President of Engineering at Cryomedical Sciences Inc. Dr. Chang received his bachelor's degree in refrigeration engineering in 1983 and master's degree in cryogenic engineering in 1985, both from University of Shanghai for Science and Technology. In 1992, he received his doctoral degree in Biological Science from State University of New York (Binghamton). Dr. Chang has published extensively in biomedical fields and holds dozens of patents in the United States and in China.
Norihiro AshidaNon-executive Director
Mr. Norihiro Ashida, born in 1954, is a Non-executive Director of our Company. Mr. Ashida has served as a Director since 1 November 2006 and has also served as a Director of MP Shanghai since March 2004. Mr. Ashida is currently holding directorship in certain subsidiaries of the Group. Mr. Ashida is an Executive Operating Officer of Otsuka Holdings Co., Ltd. ("Otsuka Holdings") and the Director of its corporate development department. Mr. Ashida is also a Director of Otsuka Medical Devices Co., Ltd. He joined Otsuka Pharmaceutical Co., Ltd. ("Otsuka Pharmaceutical") in April 2003 from Mizuho Corporate Bank Ltd., where he was a general manager from 2002 to 2003. From 1999 to 2002, Mr. Ashida was a general manager of the Industrial Bank of Japan ("IBJ"), where he headed the credit department for western Japan. From 1995 to 1999, Mr. Ashida served as Vice President responsible for business development at 3iBJ Ltd., a venture capital firm formed by 3i Group plc and IBJ. From 1989 to 1995, Mr. Ashida was a Senior Vice President of IBJ (Canada). He joined IBJ in 1977 in its Tokyo branch. Mr. Ashida received his bachelor's degree in economics from the University of Tokyo in 1977.
Hiroshi ShirafujiNon-executive Director
Mr. Hiroshi Shirafuji, born in 1944, is a non-executive Director of our Company. Mr. Shirafuji has served as a Director since 1 November 2006 and is also a director of certain subsidiaries of the Group. Mr. Shirafuji is the President of Otsuka Medical Devices Co., Ltd. ("OMD"), a subsidiary of Otsuka Holdings Co., Ltd. ("Otsuka Holdings"). Prior to joining OMD in February 2011, he was an executive director responsible for pharmaceuticals marketing at Otsuka Pharmaceutical from 1997 to 1998. Mr. Shirafuji joined Otsuka Pharmaceutical in 1967. Mr. Shirafuji received his bachelor's degree in economics from Doshisha University in Kyoto in 1967. Mr. Shirafuji was also appointed as President and CEO, representative director of Otsuka Medical Devices Co., Ltd. in February 2011.
Hongliang YuNon-executive Director
Mr. Yu, born in 1974, is currently the general manager of Zhangjiang Science & Technology Venture Capital Co., Ltd. Mr. Yu joined Shanghai Zhangjiang (Group) Co., Ltd. in November 2000, and successively served as the vice manager and executive vice manager of investment management department of Shanghai Zhangjiang (Group) Co., Ltd., vice general manager of Shanghai Zhangjiang Biotech & Pharmaceutical Base Development Co., Ltd., vice general manager of Shanghai Zhangjiang Science & Technology Venture Capital Co., Ltd. and general manager of Shanghai Putong District Small-credit Co., Ltd. Mr. Yu graduated from East China University of Metallurgy majoring in Ferrous Metallurgy with a bachelor degree in July 1996, and graduated from University of Shanghai for Science and Technology majoring in management engineering with a master degree in April 2001. Mr. Yu holds the professional title of economist and qualification of certified public accountant.
Jonathan H. ChouIndependent Non-executive Director
Mr. Jonathan H. Chou, born in 1964, was appointed as our independent non-executive Director ("INED") on 3 September 2010. Mr. Chou has more than 25 years of professional experience from various senior finance leadership positions with Fortune 500 companies as well as Asia headquartered U.S. listed companies. These companies include Honeywell International and Tyco Fire & Security (ADT) where he held the position of Asia Pacific Chief Financial Officer. More recently, Mr. Chou held the position of Chief Financial Officer of Kulicke & Soffa (NASDAQ: KLIC), a USD$2 Billion market capitalization company from 2010 to 2018. K&S is a leading provider of semiconductor packaging and electronic assembly solutions supporting the global automotive, consumer, communications, computing and industrial segments. Mr. Chou holds an MBA from Duke University, Fuqua School of Business, North Carolina and a B.A. from the University at Buffalo, New York.
Guoen Liu Ph.DIndependent Non-executive Director
Dr. Guoen Liu, born in 1957, was appointed as our Independent Non-executive Director on 3 September 2010. Dr. Liu is a noted scholar in the fields of health and development economics, health reform and pharmaceutical economics. Dr. Liu has served as professor of economics at Guanghua School of Management of Peking University, executive director of the Guanghua School of Management Health Economics and Management Institute of Peking University, and director of the China Center for Pharmaceutical Economics and Outcomes Research of Peking University since 2006. From 2000 to 2006, Dr. Liu was tenured associate professor of University of North Carolina at Chapel Hill. From 1994 to 2000, Dr. Liu was assistant professor of University of Southern California. Dr. Liu also serves as editor or a member of the editorial board in various periodic in the field of pharmaceutical economics. Dr. Liu received his bachelor's degree in mathematics from Southwestern University for Nationalities in 1981, his master's degree in statistics from Southwestern University of Finance and Economics in 1985, his Ph.D. in economics from the City University of New York in 1991, and post-doctoral training in health economics from Harvard University in 1994.
Chunyang ShaoIndependent Non-executive Director
Mr. Chunyang Shao was appointed as the Independent Non-executive Director on 23 September, 2016. Mr. Shao is currently a partner of JunHe LLP and a member of the All China Lawyers Association and Shanghai Bar Association. Mr. Shao specializes in corporate, foreign investment, real estate, mergers and acquisitions, securities, infrastructure and project finance. From July 1988 to October 1993, Mr. Shao worked in Anhui Foreign Economy Law Office. From November 1995 to March 2002, Mr. Shao worked in the London, Hong Kong and China offices of major international law firms of Simmons & Simmons as Chinese legal counsel and Sidley Austin as a senior legal consultant. Mr. Shao joined JunHe LLP in April 2002. Mr. Shao is currently the independent director of Changjiang & Jinggong Steel Building (Group) Co., Ltd. ( 长江精工钢结构( 集团) 股份有限公司), a company listed on Shanghai Stock Exchange (stock code: 600496). Mr. Shao received his bachelor degree in law from East China University of Political Science and Law in 1987, and was admitted to practice PRC law in 1988. From 1993 to 1994, Mr. Shao worked as visiting lawyer in Sino-Britain Young Lawyers' Exchange Program in the UK. In 2002, he received his master degree in law from East China University of Political Science and Law.